ストックスクリーナーアプリを入手
0.7775
4.50%
0.0335
前日終値:
$0.744
開ける：
$0.76
24時間の取引高:
467.73K
Relative Volume:
0.42
時価総額：
$100.43M
収益：
-
当期純損益:
$-26.91M
株価収益率:
-3.5341
EPS:
-0.22
ネットキャッシュフロー:
$-19.57M
1週間 パフォーマンス:
+0.13%
1か月 パフォーマンス:
-9.52%
6か月 パフォーマンス:
-2.23%
1年 パフォーマンス:
-43.25%
1日の値動き範囲:
$0.7448
$0.79
1週間の範囲:
$0.7313
$0.7994
52週間の値動き範囲:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
名前
Atossa Therapeutics Inc
セクター
電話
206.588.0256
住所
10202 5TH AVENUE NE, SEATTLE, WA
ATOS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.7775 | 102.05M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-01-26 | 開始されました | Maxim Group | Buy |
Atossa Therapeutics Inc (ATOS) 最新ニュース
Atossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer - GuruFocus
13,000 Annual Metastatic Cases: Atossa's New Breast Cancer Drug Trial Could Reshape Treatment - Stock Titan
How to track smart money flows in Atossa Therapeutics Inc.Market Weekly Review & Daily Stock Trend Watchlist - Newser
Measuring Atossa Therapeutics Inc.’s beta against major indicesJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser
Chart overlay techniques for tracking Atossa Therapeutics Inc.Earnings Performance Report & Weekly Momentum Stock Picks - Newser
Custom watchlist performance reports with Atossa Therapeutics Inc.Analyst Downgrade & Safe Capital Growth Plans - Newser
Technical analysis overview for Atossa Therapeutics Inc. stock2025 Price Action Summary & AI Driven Price Predictions - Newser
Building trade automation scripts for Atossa Therapeutics Inc.Market Trend Report & Reliable Entry Point Alerts - Newser
Using RSI to spot recovery in Atossa Therapeutics Inc.July 2025 Snapshot & Free Real-Time Market Sentiment Alerts - Newser
Institutional scanner results for Atossa Therapeutics Inc.2025 Market WrapUp & Safe Entry Point Identification - Newser
Is It Too Early to Call Recovery in Atossa Therapeutics Inc.Insider Buying & Real-Time Stock Movement Alerts - classian.co.kr
Can momentum traders help lift Atossa Therapeutics Inc.2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser
Leading vs lagging indicators on Atossa Therapeutics Inc. performanceTrade Exit Report & Comprehensive Market Scan Insights - Newser
Applying sector rotation models to Atossa Therapeutics Inc.Market Risk Analysis & Long-Term Safe Investment Ideas - Newser
Why Atossa Therapeutics Inc. stock attracts strong analyst attention2025 Big Picture & Entry Point Confirmation Signals - Newser
What does recent volatility data suggest for Atossa Therapeutics Inc.2025 Risk Factors & Expert Curated Trade Setups - Newser
Will Atossa Therapeutics Inc. benefit from macro trendsRisk Management & Verified Short-Term Trading Plans - Newser
New Product Launches: Will They Boost Atossa Therapeutics Inc. Stock in 20252025 Analyst Calls & Safe Entry Point Identification - Newser
Atossa Therapeutics reports progress in breast cancer treatments - MSN
How Atossa Therapeutics Inc. stock performs during market volatilityQuarterly Market Review & Weekly Momentum Picks - newsyoung.net
What the charts say about Atossa Therapeutics Inc. todayWeekly Trend Report & Smart Money Movement Alerts - Newser
What recovery options are there for Atossa Therapeutics Inc.July 2025 EndofMonth & Pattern Based Trade Signal System - Newser
HC Wainwright Expects Reduced Earnings for Atossa Genetics - Defense World
Does Atossa Therapeutics Inc. show high probability of reboundQuarterly Profit Summary & Long Hold Capital Preservation Tips - Newser
Multi asset correlation models including Atossa Therapeutics Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - Newser
Trendlines Converge — Decision Point for Atossa Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Opportunities - beatles.ru
Published on: 2025-08-15 04:52:23 - Newser
Atossa Therapeutics Advances Breast Cancer Treatments - TipRanks
Technical Heatmap Flags Atossa Therapeutics Inc. for WatchMarket Volume Summary & Fast Gain Swing Alerts - newsyoung.net
What makes Atossa Therapeutics Inc. stock price move sharplyBuy Signal & Low Drawdown Trading Strategies - Newser
Should you wait for a breakout in Atossa Therapeutics Inc.IPO Watch & Low Drawdown Investment Strategies - Newser
Ranking Atossa Therapeutics Inc. among high performing stocks via toolsTrade Analysis Summary & AI Optimized Trade Strategies - Newser
What does recent volatility data suggest for Atossa Therapeutics Inc. [July 2025 News Drivers]Weekly Breakout Opportunity Watchlist - Newser
Atossa Therapeutics Inc. stock momentum explainedDaily Breakout List with Smart Filters - Newser
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Positive FDA Feedback and Promising Phase 2 Results Justify Buy Rating for Atossa Therapeutics - TipRanks
Atossa Therapeutics Inc (ATOS) 財務データ
収益
当期純利益
現金流量
EPS
Atossa Therapeutics Inc (ATOS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Remmel H. Lawrence | Director |
Mar 26 '25 |
Buy |
0.70 |
10,000 |
7,000 |
10,257 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):